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The Gram-positive bacterium Lactococcus lactis is a useful host for extracellular protein production. 
A main advantage of L. lactis over other bacterial expression systems is that lactococcal cells display 
low levels of autolysis and proteolysis. Previously, we developed a set of vectors for nisin-inducible 
extracellular production of N- or C-terminally hexa-histidine (His6)-tagged proteins. The present 
study was aimed at expanding our portfolio of L. lactis expression vectors for protein purification and 
site-specific labeling. Specifically, we present two new groups of vectors allowing N- or C-terminal 
provision of proteins with Strep- or AVI-tags. Vectors for AVI-tagging encode an additional His6-tag 
for protein purification. Another set of vectors allows removal of N-terminal Strep- or His6-tags from 
expressed proteins with the tobacco etch virus protease. Two possible applications of the developed 
vectors are presented. First, we show that Strep-tagged LytM of Staphylococcus aureus in the growth 
medium of L. lactis can be directly bound to microtiter plates coated with an affinity reagent, and 
used for enzyme-linked immunosorbent assays. Second, we show that the AVI-tagged Sle1 protein 
from S. aureus as produced in L. lactis can be directly biotinylated and fluorescently labeled. The 
fluorescently labeled Sle1 was successfully applied for S. aureus re-binding studies, allowing 
subcellular localization by fluorescence microscopy. In conclusion, we have developed a set of 
expression vectors that enhance the versatility of L. lactis as a system for production of proteins with 







The Gram-positive bacterium Lactococcus lactis is known to be a suitable host for the expression and 
secretion of heterologous proteins 1. In most L. lactis expression systems, the production of proteins is 
induced using the nisin-inducible (NICE) system. Here the expression of a target gene is directed by 
the nisA promoter, which is activated in the presence of the food-grade lantibiotic nisin that activates 
the NisRK two-component regulatory system 2,3. Recently, a set of vectors suitable for inducible 
extracellular protein production of N- or C-terminally hexa-histidine (His6)-tagged proteins was 
published 4. The His6-tagged proteins were secreted via the Sec secretion machinery using the signal 
peptide of the lactococcal protein Usp45.  
The His6-tag is one of the most widely used tags as, in principle, it allows efficient one-step 
purification of tagged proteins by metal affinity chromatography 5. However, this tag can have several 
drawbacks. For example, there may be many contaminating proteins 6, and the His6-tag may lead to 
protein dimerization 7, instability or degradation of tagged proteins 8. Also, His6-tags may interfere 
with ligand or substrate binding 9. Therefore, the use of alternative protein tags could increase the 
chances of obtaining efficient protein production and purification and, at the same time, provide 
opportunities for direct labeling applications. For the isolation or labeling of expressed proteins 
several tags have been used in L. lactis, such as the Strep-tag 10, Flag-tag 11, Myc-tag 12–14 and AVI-
tag 15. Only for the last two tags, secretion of heterologous tagged proteins was demonstrated in L. 
lactis. 
The Strep-tag II system is based on an 8 amino acid peptide tag (WSHPQFEK) with reversible high 
affinity to Strep-Tactin (an engineered form of streptavidin). It is derived from the well-known 
extremely high-affinity binding of biotin to streptavidin 16.  The short, biologically inert and 
proteolytically stable peptide tag allows purification of biologically active Strep-tagged fusion 
proteins under mild conditions 17. Cytoplasmic expression of a C-terminal Strep-tag fusion in L. lactis 
using the NICE system was shown for the LmrR protein 10.  
The AVI-tag system involves a 15 amino acid peptide (GLNDIFEAQKIEWHE) recognized by the 
biotin ligase BirA that catalyzes the amide linkage between biotin and the lysine residue in the AVI-
tag peptide 18. Production in L. lactis of secreted staphylococcal proteins with an N-terminal AVI-tag 
for site-specific labeling with biotin has been reported recently 15.  
The present study was aimed at expanding our portfolio of L. lactis expression vectors. Specifically, 
we constructed two vector sets by introducing sequences encoding N- or C-terminal AVI- or Strep-
tags. The functionality of these vectors was demonstrated by expressing and secreting the tagged 
staphylococcal proteins LytM and Sle1. The produced secreted proteins were used for rapid immune 
screening, and direct labeling for detection of localized binding on staphylococcal cells, respectively.  
Materials and Methods 
Bacterial strains and growth conditions 
Strains and plasmids are listed in Table 1. L. lactis strains were grown in M17 broth (Oxoid Limited, 
Hampshire, United Kingdom) at 30ºC either as standing cultures, or by shaking (250 rpm). The M17 
broth was supplemented with 0.5% or 2% glucose (w/v) (GM17), as indicated. When necessary, the 
medium was supplemented with chloramphenicol (5 µg/ml). The S. aureus strains USA300 and 
NCTC8325 were grown overnight at 37ºC, 250 rpm in Tryptone Soy Broth (TSB; Oxoid Limited).  
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General molecular biology 
Enzymes and buffers were obtained from New England Biolabs (NEB, Ipswich, USA). Genomic 
DNA of S. aureus USA300, used as template for all PCR reactions, was isolated with the Genelute 
bacterial genomic DNA kit (Sigma-Aldrich, Zwijndrecht, The Netherlands) according to the 
manufacturer’s protocol with minor modifications as described before 15. PCR reactions were 
performed with a Bio-Rad C1000 Thermal cycler (Bio-Rad Laboratories, Richmond, CA). Primers 
used in this study, shown in Table 2, were obtained from Eurogentec (Maastricht, The Netherlands). 
The Taq (Life Technologies, Bleiswijk, The Netherlands) and Phusion Hot Start II (Thermo Fisher 
Scientific, Wilmington, Delaware USA) polymerases were used according to the manufacturer’s 
protocols. PCR products were purified using the High Pure PCR purification kit (Analytic Jena, Jena, 
Germany). Ligations with T4 DNA ligase and DNA restriction endonuclease digestions were 
performed following the manufacturer's protocols (NEB). Plasmids from L. lactis cells were extracted 
using the innuPREP Plasmid Mini Kit (Analytik Jena) with the following modifications: cell pellets 
were resuspended in solution A with lysozyme (2 mg/ml, Sigma-Aldrich) and incubated 10 min at 
55ºC. Further DNA purification and concentration were performed with the DNA Clean & 
Concentrator-5 (Zymo Research, Irvine, CA. USA). The Silica Bead DNA Gel Extraction Kit 
(Thermo Fisher Scientific) was used for DNA isolation from agarose gels. Nucleotide sequence 
analyses were performed by Eurofins DNA (Ebersberg, Germany). Electrotransformation of L. lactis 
was performed using a Gene pulser (Bio-Rad Laboratories) as described before 19. 
 
Table 1 Bacterial strains and plasmids used in this study 
Strain or plasmid Relevant phenotype(s) or genotype(s) Reference 
Strains   
L. lactis PA1001 MG1363 pepN::nisRK, allows nisin inducible expression, ΔacmA ΔhtrA 12 
S. aureus USA300 Community-acquired MRSA isolate 20 
S. aureus NCTC8325 Restriction-deficient derivative of NCTC 8325; cured of all known prophages 21 
Plasmids   
pNG4110 CmR, containing PnisA, SSusp45, N-term His6, MCS 4 
pNG4111 CmR, containing PnisA, SSusp45, N-term His6, TEV-site, MCS 4 
pNG4210 CmR, containing PnisA, SSusp45, MCS, C-term His6 4 
pNG4110S pNG4110 derivative with Strep-Tag II replacing His6 tag This study 
pNG4111S pNG4111 derivative with Strep-Tag II replacing His6 tag This study 
pNG4210S pNG4210 derivative with Strep-Tag II replacing His6 tag This study 
pNG4110A pNG4110 derivative with a C-term AVI-tag This study 
pNG4111A pNG4111 derivative with a C-term AVI-tag This study 
pNG4210A pNG4210 derivative with N-term AVI-tag This study 
pNG4110-lytM pNG4110 expressing mature LytM fused to SSusp45 and N-term His6 This study 
pNG4111- lytM pNG4111 expressing mature LytM fused to SSusp45, N-term His6 and TEV-site This study 
pNG4210- lytM pNG4210 expressing mature LytM fused to SSusp45 and C-term His6 This study 
pNG4110S- lytM pNG4110S expressing mature LytM fused to SSusp45 and N-term Strep-Tag II This study 
pNG4111S- lytM pNG4111S expressing mature LytM fused to SSusp45, N-term Strep-Tag II and TEV-site This study 
pNG4210S- lytM pNG4210S expressing mature LytM fused to SSusp45 and C-term Strep-Tag II This study 
pNG4110A- lytM pNG4110A expressing mature LytM fused to SSusp45, N-term His6 and C-term AVI-tag This study 
pNG4111A- lytM pNG4111A expressing mature LytM fused to SSusp45, N-term His6, TEV-site, C-term AVI-tag This study 
pNG4210A- lytM pNG4210A expressing mature LytM fused to SSusp45, C-term His6 and N-term AVI-tag This study 
pNG4110-sle1 pNG4110 expressing mature Sle1 fused to SSusp45 and N-term His6 This study 
pNG4110- sle1 pNG4111 expressing mature Sle1 fused to SSusp45, N-term His6 and TEV-site This study 
pNG4111- sle1 pNG4210 expressing mature Sle1 fused to SSusp45 and C-term His6 This study 
pNG4210- sle1 pNG4110S expressing mature Sle1fused to SSusp45 and N-term Strep-Tag II This study 
pNG4110S- sle1 pNG4111S expressing mature Sle1fused to SSusp45, N-term Strep-Tag II and TEV-site This study 
pNG4111S- sle1 pNG4210S expressing mature Sle1fused to SSusp45 and C-term Strep-Tag II This study 
pNG4210S- sle1 pNG4110A expressing mature Sle1fused to SSusp45, N-term His6 and C-term AVI-tag This study 
pNG4110A- sle1 pNG4111A expressing mature Sle1fused to SSusp45, N-term His6 , TEV-site, C-term AVI-tag This study 
pNG4111A- sle1 pNG4210A expressing mature Sle1 fused to SSusp45, C-term His6 and N-term AVI-tag This study 
CmR, chloramphenicol resistance gene; PnisA, nisin-inducible promoter; His6, hexahistidine-tag; SSusp45, signal sequence of usp45; 





Table 2. Primers used for the construction of the expression vectors 
Primer 5' → 3' nucleotide sequence a R.E. 
StrepTag.For CAATGATTTCGTTCGAAGGAACTAC BstBI 
Strep110.Rev   ATATGGATCCTTTCTCGAACTGCGGGTGGCTCCACATGGAGTTTGTGTCAGCGTAAAC  BamHI 
Strep111.Rev   ATATGGATCCCTGGAAGTACAGGTTCTCTTTCTCGAACTGCGGGTGGCTCC  BamHI 
Strep210.Rev   ATATAAGCTTTTATTTCTCGAACTGCGGGTGGCTCCATGCGGCCGCCTCGAGGAATTCG  HindIII 
StrepPCR.Rev CTCGAACTGCGGGTGGCTCC  
AVI-tagNotI.fw  GGCCGCCATGAGTGGTTTAAACGATATTTTCGAGGCTCAGAAAATCGAATGGCACGAATAAATCC  
AVI-tagNotI.rev  GGCCGGATTTATTCGTGCCATTCGATTTTCTGAGCCTCGAAAATATCGTTTAAACCACTCATGGC  
AVI-tagBamHI.fw  GATCGCCCATGAGTGGTTTAAACGATATTTTCGAGGCTCAGAAAATCGAATGGCACGAAATCATGG  
AVI-tagBamHI.rev  GATCCCATGATTTCGTGCCATTCGATTTTCTGAGCCTCGAAAATATCGTTTAAACCACTCATGGGC  
SleI.F1 ATATGGATCCGCTACAACTCACACAGTAAAAC BamHI 
SleI.R1 ATATGCGGCCGCGTGAATATATCTATAATTATTTACTTGGT NotI 
SleI.R2 ATATGCGGCCGCTTAGTGAATATATCTATAATTATTTACTTGGT NotI 
LytM.F1 ATATGGATCCATGGGAGCAGAAACGACAAACACCC BamHI 
LytM.R1 ATATGCGGCCGCTCTACTTTGCAAGTATGACGTTGGG NotI 
LytM.R2 ATATGCGGCCGCTTATCTACTTTGCAAGTATGACGTTGGG NotI 
a Restriction site underlined, stop codon in bold, NotI/BamHI-compatible overhangs in italics 
 
Construction of expression vectors 
An overall schematic representation of constructed vectors is shown in Fig. 1. The His6-tag present in 
plasmids pNG4110, pNG4111 and pNG4210 was replaced by the Strep-tag II resulting in the 
plasmids pNG4110S, pNG4111S and pNG4210S, respectively. For the construction of plasmid 
pNG4110S, a PCR fragment was generated using the primers StrepTag.For and Strep110.Rev using 
plasmid pNG4110 as a template. The PCR product was digested with BstBI and BamHI and ligated to 
linearized plasmid pNG4110, digested with the same enzymes. The same approach was used to 
replace the His6-tag to obtain plasmids pNG4111S and pNG4210S using specific primers indicated in 
Table 2. Insertion of the AVI-tag in plasmids pNG4110, pNG4111 and pNG4210 resulted in plasmids 
pNG4110A, pNG4111A and pNG4210A, respectively. For the construction of plasmid pNG4110A 
and pNG4111A, primers AVI-tagNotI.fw and AVI-tagNotI.rev were annealed to obtain a double 
stranded DNA fragment with NotI-compatible sticky ends, which was ligated to the NotI-linearized 
plasmids pNG4110 and pNG4111. In the same manner primers AVI-tagBamHI.fw and AVI-
tagBamHI.rev were annealed and ligated to the BamHI-linearized plasmid pNG4210, resulting in 
plasmid pNG4210A. To construct lytM and sle1-expressing plasmids, PCR products amplified from 
S. aureus USA300 genomic DNA with primers indicated in Table 2 were digested with BamHI and 
NotI, and ligated to BamHI/NotI-linearized vectors. Primer combinations using a reverse primer with 
a stop codon (F1/R2) were used to amplify fragments for ligation to plasmids pNG4110, pNG4111, 
pNG4110S and pNG4111S, and primer combinations without a stop codon in the reverse primer 
(F1/R1) were used to amplify fragments for ligation into plasmids pNG4210, pNG4210S, 
pNG4110A, pNG4111A and pNG4210A.  
Protein expression, purification and detection 
For protein expression lactococcal cultures were induced in the exponential phase of growth at an 
optical density at 600 nm (OD600) of 0.5 by the addition of nisin (final concentration 3 ng/ml; Sigma-
Aldrich, St. Luis, MO), and harvested after overnight incubation. Cells were then separated from the 
growth medium by centrifugation. Nisin-induced culture supernatants were precipitated with 10% 
TCA and resuspended in LDS sample buffer (Life Technologies, Grand Island, NY. USA). The 
respective cells were disrupted with 0.1 µm glass beads in LDS sample buffer (Biospec Products, 
Bartlesville, USA) in a Precellys 24 homogenizer (Bertin Technologies, Saint Quentin en Yvelines 
Cedex, France). Secreted and cellular proteins were analyzed by LDS-PAGE using NuPAGE gels 
(Life Technologies). Proteins were either visualized using Simply Blue Safe Staining (Life 
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Technologies), or by Western blotting on nitrocellulose membranes (Protan nitrocellulose transfer 
paper. Whatman, Germany) using mouse anti-His6-tag (Life Technologies), anti-Strep tag II (Iba 
Lifesciences, Germany) or anti-AVI-tag (Genscript, Piscataway, USA) primary antibodies. 
Fluorescent secondary antibodies (goat anti-mouse IRDye 800 CW, LI-COR Biosciences, Lincoln, 
NE. USA) were used for visualization of bound primary antibodies with an Odyssey Infrared Imaging 
System (LI-COR Biosciences). Expressed Strep-tag II proteins were purified from growth medium 
fractions (adjusted to pH 8 with NaOH) using a Strep-Tactin Sepharose 50% suspension following the 
manufacturer's protocol (Iba Lifesciences). AVI-tagged Sle1 proteins in cell fractions (Sle1-AVI 
pellets) were washed twice with phosphate-buffered saline (PBS) and labeled directly with biotin 
using the BirA biotin ligase (Avidity, Aurora, CO. USA). Cell pellets were then washed twice with 
PBS and incubated with 0.1 mg Cy3-streptavidin (GE Healthcare Europe, Germany) in PBS for 30 
min. After two washes with PBS, pellets were incubated in 6M urea for 10 min and cell-bound Cy3-
Sle1 released to the supernatant was collected after centrifugation. To observe possible non-specific 
binding of Cy3-streptavidin to biotinylated native L. lactis proteins, Sle1-AVI pellets were washed 
twice with PBS, and incubated with 0.1 mg Cy3-streptavidin in 6M urea for 10 min. After 
centrifugation the supernatant was collected and used as Cy3 negative control supernatant. 
Enzyme-linked immunosorbent assays (ELISA) 
Strep-tactin-coated microtiter plates (8-well strips, Iba Lifesciences) were incubated for 1 hour at 
room temperature with nisin-induced filter-sterilized growth medium samples (100 µl/well, adjusted 
to pH 8 with NaOH) containing LytM Strep-tag II fusion proteins. Serial dilutions of previously 
collected human plasma samples (500–2,000,000) were made in PBS-Tween 20/5% skim milk. The 
plasma samples used were obtained from a patient with epidermolysis bullosa (EB01) and a healthy 
control volunteer (Control 02) as previously described 22. Specific anti-human IgG secondary 
antibodies coupled to horseradish peroxidase (dilution 1:2,000, Southern Biotechnology, 
Birmingham, AL) were used according to the manufacturer recommendations. Horseradish 
peroxidase activity was quantified by measuring the hydrolysis of the substrate (O-Phenylenediamine, 
Sigma-Aldrich) at an optical density of 492 nm (OD492) in a plate reader (Biotek Powerwave XS2, 
USA). Titers were expressed in arbitrary units (AU) obtained by calculating in Excel the extrapolated 
initial absorbance at serum dilution 1:1 (titer), using a linear regression equation adjusted through the 
data points of dilutions with measured OD495 readings between 1.0 and 0.1 (SLOPE(sample OD 
readings data set, serum dilution factor data set)+ INTERCEPT(sample OD readings data set, serum 
dilution factor data set)), with all R2 (Pearson product moment correlation coefficient) values > 0.98. 
Estimated titers of duplicates were averaged. 
Microscopy 
S. aureus NCTC8325 was grown overnight in TSB and used to inoculate fresh medium (1:50) in the 
morning. This culture was then grown until the mid-exponential phase. When an OD600 of 1.0 was 
reached, 1 ml of bacterial culture was collected, washed twice with PBS and incubated in 1.5 ml of 
PBS containing 1.5 µg (30 µl) of Cy3-Sle1 or Cy3 control supernatant for 1 h at room temperature. 
After washing three times with PBS, cells were spotted onto polylysine-coated glass slides. 
Microscopic images were recorded using a Leica DM5500B epifluorescence microscope equipped 
with Cy3 filter block and a Leica DFC365FX camera using a 63x objective (Leica Microsystems BV, 
The Netherlands). The presence of Sle1 was assayed using rabbit anti-Sle1 antibodies (originally 
referred to as anti-Aaa antibodies) at a 1:500 dilution using an earlier described protocol 23. The anti-
Sle1/Aaa antibodies were kindly provided by Christine Heilmann 24. Secondary Oregon Green anti-





Plasma from an epidermolysis bullosa patient and a healthy volunteer was collected under the 
approval of the medical ethics committee of the University Medical Center Groningen (approval no. 
NL27471,042,09) upon written informed consent, and with adherence to the Helsinki Guidelines22. 
The necessary written informed consent was obtained from both plasma donors. 
Results 
Development of vectors for the secretion of Strep- or AVI-tagged proteins from L. lactis 
In order to express and secrete AVI-tag or Strep-tag fusion proteins from L. lactis the vector set 
pNG4110/111/210 was modified as depicted in Fig. 1. In a previous study these vectors were 
successfully used for the extracytoplasmic production and purification of heterologous His6-tagged 
proteins 4. The His6-tag-encoding sequences in the vectors pNG4110/111/210 were replaced by the 
Strep-tag-encoding sequence, generating the vectors pNG4110S/111S/210S (Fig. 1C). Respectively, 
these vectors can be used to express proteins with N-terminal, N-terminal and TEV-cleavable, or C-
terminal Strep-tags. Further, the AVI-tag-encoding sequence was added in the vectors 
pNG4110/111/210, respectively generating vectors pNG4110A/111A/210A, which contain both the 
His6-tag- and AVI-tag-encoding sequences (Fig. 1D). All constructed vectors were found to be 
structurally stable in L. lactis PA1001. With respect to usage of the AVI-tag, it is noteworthy that 
BLAST analysis with the AVI-tag amino acid sequence showed that none of the genes of L. lactis 
NZ9000 (i.e. the parental strain of PA1001) encodes proteins with similarity to the AVI-tag. This 
renders false-positive biotinylation of L. lactis proteins by the BirA enzyme unlikely. 
Production of Strep- or AVI-tagged fusions of the staphylococcal proteins LytM and Sle1 
To test our newly constructed ‘third-generation’ vector set for protein production in L. lactis, genes 
encoding the naturally exported S. aureus proteins LytM and Sle1 were cloned into all of these 
vectors. The resulting plasmids were then introduced and expressed in L. lactis PA1001. This strain 
lacks the gene for the major peptidoglycan hydrolase AcmA, due to which cells do not lyse during 
and after growth. Further, the PA1001 strain displays reduced proteolytic activity due to deletion of 
the htrA gene 15. After induced expression, all fusion proteins were produced as demonstrated by 
LDS-PAGE, where the respective proteins showed a mobility that matched their expected sizes (Fig. 
2).  
LytM fusion proteins were observed mainly in the growth medium fractions, but their expression 
levels varied. While LytM expression appeared slightly higher from plasmid pNG4210 (C-terminal 
His6-tag) and lower from pNG4111 (N-terminal His6-tag and TEV site), the opposite effect was 
observed for the expression of the AVI-tagged variants as expressed from the plasmids pNG4210A 
and pNG4111A (Fig. 2A). This could suggest that the tag position influences the expression and/or 
secretion efficiency of the fusion products.  
Sle1 consist of a C-terminal CHAP domain (PF05257), which is responsible for peptidoglycan 
hydrolysis, plus three N-terminal LysM domains (PF01476) that are responsible for non-covalent cell 
wall binding 25,26. Accordingly, all Sle1 fusions proteins were detected in the cell fractions upon nisin-
induced expression. Release of Sle1 from the collected cells was achieved by incubation with 6M 
urea (Fig. 2B). The urea-released Sle1 was effectively recovered by centrifugation. Of note, upon 
LDS-PAGE and Simply blue staining, no detectable amounts of proteins other than Sle1 were 
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observed in the respective supernatant fraction. As was observed for the LytM fusion proteins, the 
expression levels of Sle1 fusion proteins varied depending on the position of the tag. In the case of 
Sle1 with an N-terminal AVI-tag, hybridizing bands with apparently lower molecular weight were 
detected upon expression from vectors pNG4110A and pNG4111A (Fig. 2B). Most likely, these 
relate to degradation products of the respective Sle1 fusions. In all other cases, Sle1 was apparently 
stably produced. These data show that all fusion products could be produced form the newly 


















Figure 1. Schematic representation of the expression cassettes used in this study  
(A) Representation of the secretion signal peptides (ss) and mature regions (26-316 and 26-334) of the S. aureus 
proteins LytM and Sle1, respectively. (B) Expression cassettes of the L. lactis pNG-vectors, encoding an N-
terminal His6-tag (pNG4110), a C-terminal His6-tag (pNG4210), or a TEV-removable (TEV) N-terminal His6-tag 
(pNG4111). (C) Expression cassettes of the L. lactis pNG-vectors, encoding an N-terminal Strep-tag II 
(pNG4110S), a C-terminal Strep-tag II (pNG4210S), or a TEV-removable (TEV) N-terminal Strep-tag II 
(pNG4111S). (D) Expression cassettes of the L. lactis pNG-vectors, encoding an N-terminal His6-tag and a C-
terminal AVI-tag (pNG4110A), a C-terminal His6-tag and a N-terminal AVI-tag (pNG4210A), or a TEV-
removable (TEV) N-terminal His6-tag (pNG4111A) and a C-terminal AVI-tag. Positions of the restriction enzyme 
cleavage sites BamHI (B) and NotI (N), the TEV protease cleavage site (TEV), N-terminal or C-terminal His6-tag 
(h6), Strep-tag II (ST) and AVI-tag (AVI) are indicated. ssu, signal sequence of the gene for the secreted 


















Figure 2. Expression of various tagged derivatives of the S. aureus LytM and Sle1 proteins 
Detection of LytM (A) and Sle1 (B) expression in L. lactis by LDS-PAGE and subsequent Simply blue staining 
(upper panels) or Western blotting (lower panels) using antibodies against different tags (α-His6-tag, α-Strep-tag, 
α-Avi-tag). Expression from different vectors is indicated as follows: H0, pNG4110; H1, pNG4111; H2, 
pNG4210; S0, pNG4110S; S1, pNG4111S; S2, pNG4210S; A0, pNG4110A; A1, pNG4111A; and A2, 
pNG4210A. Lanes loaded with cell or growth medium fractions are indicated. Urea, supernatant fraction obtained 
after incubation of cells with 6M urea and centrifugation. Molecular weights of marker proteins are indicated on 
the left, and the positions of LytM and Sle1 fusion proteins or the major secreted protein of L. lactis (Usp45) are 
indicated on the right. 
 
Application of Strep-tagged LytM in an ELISA  
To test the application potential of secreted Strep-tagged staphylococcal proteins for the detection of 
specific human antibodies, we applied an ELISA approach. To this end, the Strep-tagged LytM fusion 
protein was bound to Strep-tactin-coated microwell plates. Specifically, nisin-induced culture 
supernatants of pNG4110S-lytM were added to microtiter plate wells coated with Strep-tactin. The 
plates were subsequently washed and ELISA was performed using plasma from an epidermolysis 
bullosa patient (EB01) and an age-matched healthy control individual (Control 2), both of which had 
been previously described 22. The results as presented in Fig. 3 show that the EB01 plasma contained 
a substantially higher level of anti-LytM IgG (2177.5 AU) than the Control 2 plasma (237 AU), 
which is in full agreement with our previous observations. This shows that Strep-tagged fusions of S. 
aureus proteins expressed and secreted in L. lactis can be directly recovered from growth medium 
fractions and used for ELISA.  
Use of the AVI-tag to assess localized Sle1-binding to S. aureus cells 
A Sle1 fusion protein with an N-terminal His6-tag and a C-terminal AVI-tag was obtained upon 
expression from pNG4110A-sle1. Of note, this fusion protein fractionated with the expressing cells 
(Fig. 2B). To assess whether the cell-associated AVI-tagged Sle1 can be directly labeled with biotin, 
the producing L. lactis cells were collected and incubated with biotin and the BirA ligase. 
Subsequently, the cells were washed and incubated with Cy3-streptavidin. The resulting Cy3-Sle1 
was released from the L. lactis cells by incubation with 6M urea. Lastly, upon centrifugation, the 
supernatant fraction containing Cy3-Sle1 was diluted 50-fold and added to S. aureus NCTC8325 
cells. Fluorescence microscopy showed that Cy3-labeled Sle1 bound locally on the surface of S. 
aureus NCTC8325 cells with a preference for the septal region (Fig. 4A). Similar hotspots for binding 
B 
A 
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were observed when using Sle1-specific antibodies in combination with a secondary Oregon green-
labeled antibody (Fig. 4B). In this case, a S. aureus Δspa Δsbi double mutant strain was used for the 
immunodetection in order to avoid Fc-specific IgG-binding by Protein A and Sbi. Of note, a possible 
interference by Protein A and Sbi is not an issue when using the Cy3-labeled AVI-tagged Sle1 fusion 
protein. To control for possible Cy3-labeling of biotinylated native L. lactis proteins, L. lactis cells 
expressing the AVI-tagged Sle1 fusion protein were incubated as described above, but in  the absence 
of the BirA ligase. Upon extraction of the AVI-tagged Sle1 from the L. lactis cells and subsequent 
incubation with S. aureus NCTC8325 cells, no labeling of the staphylococcal cells was observed (Fig. 
4C). This shows that an AVI-tagged protein produced in L. lactis can be effectively labeled with 













Figure 3. ELISA of strep-tagged LytM using human plasma 
Strep-tagged LytM was bound to a Strep-tactin 96-well microtiter plate by applying growth medium fractions of L. 
lactis pNG4110S-lytM. Upon washing of the plate, ELISA was performed using the human plasma samples EB01 









Figure 4. Binding of AVI-tagged Cy3-labeled Sle1 to S. aureus NCTC8325 cells 
(A) Fluorescence microscopy of S. aureus NCTC8325 cells upon incubation with AVI-tagged Cy3-labeled Sle1. 
(B) Incubation of S. aureus cells with Sle1-specific antibodies. (C) Negative control of cells incubated with non-





In this study we describe a third-generation set of cloning vectors for the expression and secretion of 
differently tagged heterologous protein from L. lactis. These vectors enable isolation of proteins 
under mild conditions using Strep-tag fusions or site-specific labeling with biotin using AVI-tag 
fusions. For both types of tags, N-terminal, C-terminal or TEV-protease cleavable C-terminal fusion 
proteins can be produced. A secreted Strep-tag fusion of the staphylococcal protein LytM was 
successfully used for rapid immune screening using human sera. An AVI-tagged variant of the 
staphylococcal Sle1 protein was site-specifically labeled and used for detection of localized binding 
on staphylococcal cells. 
The combination of nisin-inducible expression using the L. lactis PA1001 strain allowed for 
controlled stable overnight expression of all fusion proteins. As expected based on the autolysin- and 
protease-deficiency of the PA1001 strain, no autolysis was detectable for any of the fusion protein-
expressing derivative strains, and product degradation appears to be negligible. Only a minor possible 
degradation product of AVI-tagged Sle1 proteins was detectable upon overnight expression. This is in 
agreement with earlier reports from this strain where a possible involvement of cytoplasmic or 
intramembrane proteases was invoked in residual product degradation 4. 
Measurements of human immune responses against S. aureus LytM were previously performed by 
ELISA 27 and Luminex bead-based flow cytometry 22. In both cases, the analyses involved the 
purification of His6-tagged LytM and subsequent binding of the purified protein to ELISA plates or 
Luminex beads. As shown in our present study, expression of LytM with a Strep-tag obviates the 
purification step as Strep-tagged LytM secreted by L. lactis can be directly applied to Strep-tactin-
coated microplate wells for LytM immobilization on the plates. Importantly, the recorded human IgG 
binding by immobilized LytM matched well with the previously published data, where it was shown 
that plasma samples from S. aureus-colonized epidermolysis bullosa patients contained significantly 
higher levels of anti-LytM IgGs than plasma samples from healthy control individuals 22,28.  
Previously, the microscopic detection of non-covalently cell wall-bound S. aureus proteins has been 
performed in various different ways, including immunofluorescence with labeled antibodies 29, in 
frame fusions to fluorescent proteins like mCherry 30 or GFP 14, or re-binding of purified proteins that 
had been randomly labeled with fluorophores 31. Of note, such approaches may have certain 
drawbacks. In particular, in immunofluorescence microscopy, the presence of the IgG-binding 
proteins Spa (protein A) and Sbi results in an Fc-dependent off-target signal. This can be overcome 
by using spa sbi mutant strains, but it precludes analyses with clinical S. aureus isolates. The use of 
in-frame fusions between a protein of interest and fluorescent proteins, may be hampered by low 
signal intensities due to low expression levels, possible misfolding of the fluorescent protein, or 
incompatibilities with the protein secretion machinery. Further, random labeling of proteins used in 
re-binding studies can potentially interfere with the binding function of the protein. Our present 
results show that the AVI-tag allows for direct labeling of AVI-tagged Sle1 protein with Cy3-
streptavidin. The resulting fluorescently marked Sle1 protein could then be used for re-binding studies 
with staphylococcal cells. Previously, Frankel and Schneewind 30 used mCherry fused to Sle1 for S. 
aureus cell wall-binding studies to demonstrate the septal binding of Sle1. In our present approach, 
the previously observed preferential septal binding of Sle1 was clearly reproduced, indicating that the 
AVI-tag can be used as an alternative to in-frame fusions with fluorescent proteins. Of note, with the 
AVI-tagged Sle1, we also obtained possible evidence for additional sites of localized binding to S. 
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aureus (Fig. 3A). The latter observation deserves further investigations, to identify the direct or 
indirect nature of the respective interactions and their possible biological relevance. 
In conclusion, we have developed a set of third generation expression vectors that enhance the 
versatility of L. lactis as a system for the production of proteins carrying tags that can be used for 
affinity purification and site-specific protein labeling. 
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